Blume-Jensen Peter Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$82,124.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Blume-Jensen Peter

According to the SEC Form 4 filings, Blume-Jensen Peter, being in a position of

  1. President and CEO at Acrivon Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 49000 shares for $82,124, and sold 15749 shares for $34,412,
    over all time since 2026-01-14, has bought 49000 shares for $82,124, and sold 15749 shares for $34,412.

Biography of Blume-Jensen Peter

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $82,124133
Sells
 $34,412267

Comparison of Insiders on Amount of Buys and Sells

2026-08-25SaleAcrivon Therapeutics, Inc. Common Stock
ACRV
President and CEO
14,036
0.0332%
$2.21$30,969-12.39%
2026-08-18SaleAcrivon Therapeutics, Inc. Common Stock
ACRV
President and CEO
1,713
0.0039%
$2.01$3,443-3.17%
2026-01-14PurchaseAcrivon Therapeutics, Inc. Common Stock
ACRV
President and CEO
49,000
0.1422%
$1.68$82,124-5.19%
Total: 3
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.